Correlation of Bone Alkaline Phosphatase and iPTH with Some Basic Biochemical Markers in Predialysis and Dialysis Patients

被引:0
作者
Milinkovic, Neda Lj. [1 ]
Majkic-Singh, Nada T. [1 ]
Ignjatovic, Svetlana D. [1 ]
Lezaic, Visnja D. [2 ]
Pejanovic, Svetlana D. [2 ]
Jovanovic, Dijana B. [2 ]
机构
[1] Univ Belgrade, Ctr Med Biochem, Clin Ctr Serbia, Inst Med Biochem,Pharmaceut Fac, Belgrade 11000 381, Serbia
[2] Clin Ctr Serbia, Inst Nephrol & Urol, Ctr Med Biochem, Belgrade, Serbia
关键词
Biochemical markers; bone alkaline phosphatase; dialysis; parathyroid hormone; renal osteodystrophy; CHRONIC KIDNEY-DISEASE; PARATHYROID-HORMONE; HEMODIALYSIS-PATIENTS; RENAL OSTEODYSTROPHY;
D O I
10.7754/Clin.Lab.2011.110816
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Bone alkaline phosphatase (BALP) is a direct and independent indicator of impaired bone turnover. We intended to find out whether there are any significant changes in BALP and iPTH levels, in comparison to total Ca, total Mg, inorganic P, total alkaline phosphatase (ALP), and tartrate resistant acid phosphatase (TRAP) in predialysis and dialysis patients. Methods: Out of 266 patients investigated, 114 were on continuous ambulatory peritoneal dialysis, 112 were on maintenance haemodialysis, while 40 predialysis patients had end stage renal disease. The parameters were analysed according to the manufacturers' instructions. Results: Correlations were established for the bone marker concentrations analysed among the studied groups. The largest ranges were determined for BALP and iPTH. Predialysis and dialysis patients showed very low levels of BALP. Dialysis patients had lower levels of iPTH (p<0.001), while in predialysis patients the levels were significantly higher (p<0.05) than recommended for low bone turnover, according to K/DOQI. Conclusions: The observations made in this study identify BALP as a good indicator of decreased bone turnover in predialysis and dialysis patients. However, in order to reveal a difference between bone activity and the level of parathyroid activity and its effect on bone turnover, it is always necessary to observe both BALP and iPTH levels. (Clin. Lab. 2012;58:747-753. DOI: 10.7754/Clin.Lab.2011.110816)
引用
收藏
页码:747 / 753
页数:7
相关论文
共 26 条
  • [1] Aslan D, 2007, J MED BIOCHEM, V26, P309
  • [2] Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients
    Bervoets, ARJ
    Spasovski, GB
    Behets, GJ
    Dams, G
    Polenakovic, MH
    Zafirovska, K
    Van Hoof, VO
    De Broe, ME
    D'Haese, PC
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (05) : 997 - 1007
  • [3] Localization of tartrate-resistant acid phosphatase (TRAP), membrane type-1 matrix metalloproteinases (MT1-MMP) and macrophages during early endochondral bone formation
    Blumer, Michael J. F.
    Longato, Stefano
    Fritsch, Helga
    [J]. JOURNAL OF ANATOMY, 2008, 213 (04) : 431 - 441
  • [4] Damera S, 2010, KIDNEY INT, V79, P218
  • [5] Bone Alkaline Phosphatase and Mortality in Dialysis Patients
    Drechsler, Christiane
    Verduijn, Marion
    Pilz, Stefan
    Krediet, Raymond T.
    Dekker, Friedo W.
    Wanner, Christoph
    Ketteler, Markus
    Boeschoten, Elisabeth W.
    Brandenburg, Vincent
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (07): : 1752 - 1759
  • [6] Adynamic bone disease: clinical and therapeutic implications
    Frazao, Joao M.
    Martins, Patricia
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2009, 18 (04) : 303 - 307
  • [7] Use of vitamin D in chronic kidney disease patients
    Gal-Moscovici, Anca
    Sprague, Stuart M.
    [J]. KIDNEY INTERNATIONAL, 2010, 78 (02) : 146 - 151
  • [8] Serum markers of bone turnover in dialyzed patients separated according to age
    Grzegorzewska, Alicja E.
    Mlot, Monika
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2006, 38 (02) : 311 - 316
  • [9] Halleen JM, 2006, CLIN LAB, V52, P499
  • [10] Herberth J, 2006, CLIN NEPHROL, V65, P328